El-ASSAL, M. I.; SAMUEL, D. OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS. Int J Pharm Pharm Sci 2022, 14, 17-27.